These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 35544837

  • 1. Childhood vaccination coverage of hepatitis A, measles, mumps and rubella, and varicella: temporal trend analysis in Minas Gerais, Brazil.
    Oliveira GCCF, Rodrigues RN, Silva MCD, Nascimento GLMD, Lanza FM, Gusmão JD, Oliveira VC, Guimarães EAA.
    Rev Bras Epidemiol; 2022; 25():e220010. PubMed ID: 35544837
    [Abstract] [Full Text] [Related]

  • 2. Spatial behavior of hepatitis A, MMR, and varicella vaccination coverage in the state of Minas Gerais, 2020.
    Oliveira GCCF, Arroyo LH, Vimieiro AM, Gusmão JD, Oliveira VC, Guimarães EAA.
    Rev Bras Epidemiol; 2023; 26():e230030. PubMed ID: 37377251
    [Abstract] [Full Text] [Related]

  • 3. Varicella vaccines and measles, mumps, rubella, and varicella vaccine.
    Bricks LF, Sato HK, Oselka GW.
    J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S101-8. PubMed ID: 16826308
    [Abstract] [Full Text] [Related]

  • 4. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G.
    Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with incomplete vaccination and negative antibody test results for measles, mumps, and hepatitis A among children followed in the MINA-BRAZIL cohort.
    Ferreira MS, Cardoso MA, Mazzucchetti L, Sabino EC, Avelino-Silva VI.
    Rev Inst Med Trop Sao Paulo; 2023 May; 65():e16. PubMed ID: 36921204
    [Abstract] [Full Text] [Related]

  • 6. Measles-mumps-rubella-varicella combination vaccine (ProQuad): a guide to its use in children in the E.U.
    Scott LJ.
    Paediatr Drugs; 2015 Apr; 17(2):167-74. PubMed ID: 25732634
    [Abstract] [Full Text] [Related]

  • 7. Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination?
    Karadeniz A, Akduman Alaşehir E.
    J Infect Public Health; 2020 Apr; 13(4):480-484. PubMed ID: 32113699
    [Abstract] [Full Text] [Related]

  • 8. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M, Broder KR, Temte JL, Snider DE, Seward JF, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2010 May 07; 59(RR-3):1-12. PubMed ID: 20448530
    [Abstract] [Full Text] [Related]

  • 9. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F, Heffernan C, Meurice F, Ota MOC, Vetter V, Casabona G.
    Expert Rev Vaccines; 2021 Jul 07; 20(7):811-826. PubMed ID: 34096442
    [Abstract] [Full Text] [Related]

  • 10. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.
    Ciofi Degli Atti ML, Salmaso S, Bella A, Arigliani R, Gangemi M, Chiamenti G, Brusoni G, Tozzi AE, Pediatric Sentinel Surveillance Study Group.
    Pediatr Infect Dis J; 2002 Aug 07; 21(8):763-8. PubMed ID: 12192166
    [Abstract] [Full Text] [Related]

  • 11. A combination vaccine against measles, mumps, rubella and varicella.
    Knuf M, Faber J, Barth I, Habermehl P.
    Drugs Today (Barc); 2008 Apr 07; 44(4):279-92. PubMed ID: 18536786
    [Abstract] [Full Text] [Related]

  • 12. Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
    Sanftenberg L, Schrörs HJ, Schelling J.
    Vaccine; 2016 Jul 25; 34(34):3938-41. PubMed ID: 27318420
    [Abstract] [Full Text] [Related]

  • 13. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í, Köse Ş, Akbulut Í, Albayrak H.
    Rev Esp Quimioter; 2019 Dec 25; 32(6):525-531. PubMed ID: 31642641
    [Abstract] [Full Text] [Related]

  • 14. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G, Gareca M, Kincaid H, Knouse MC.
    J Travel Med; 2015 Dec 25; 22(6):396-402. PubMed ID: 26412393
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML, Martínez D, Santos-Sancho JM, Borda JR, Orero A.
    Rev Esp Quimioter; 2014 Jun 25; 27(2):98-101. PubMed ID: 24940889
    [Abstract] [Full Text] [Related]

  • 17. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
    Nolan T, McIntyre P, Roberton D, Descamps D.
    Vaccine; 2002 Dec 13; 21(3-4):281-9. PubMed ID: 12450703
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
    Leung JH, Hirai HW, Tsoi KK.
    Expert Rev Vaccines; 2015 Dec 13; 14(8):1149-57. PubMed ID: 26081133
    [Abstract] [Full Text] [Related]

  • 19. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA.
    Pediatrics; 1986 Oct 13; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [Abstract] [Full Text] [Related]

  • 20. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
    Ramet J.
    Int J Infect Dis; 2007 Nov 13; 11 Suppl 2():S49-55. PubMed ID: 18162247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.